The speed and global spread of coronavirus has brought about a huge shift in people’s behaviour, such as bulk-buying or self-isolating. The virus has led to our environment becoming increasingly ‘liquid’, subject to change and operating without familiar context and predictable patterns. With these shifts in consumer behaviour, how can brands stay relevant to want their customers want?
Coronavirus means brands need to be flexible and adapt to change. When the context and pattern in which people live changes, brands should ask themselves how can I add value considering this new reality?
As many brands seem uncertain about how, or even if, they should respond, this paper looks at how firms can pursue consumers in the right way and deliver value in a time of contextual fluidity. While, of course, it is vital to avoid being seen as a crisis profiteer, there are a number of ways brands can play enhanced roles in people’s lives in a period of time where people are out of their automatic behavioural rhythms. There is little doubt we are now making decisions in a time of distress, making us more likely to pay attention to the brands willing engage with us in the right way.
Trust and the reputation of the pharmaceutical industry: has the pandemic made a difference?
Since the global pandemic, the public have had more exposure to the power of pharma companies to improve and save lives. The sector has also been exposed to an unprecedented level of mainstream media coverage. So the big question is; has this has led to a heightened degree of trust?
A survey in eight countries about HPV reveals over a quarter of surveyed parents from across Europe are unaware of HPV
MSD commissioned Ipsos to run a survey to support speakers at the European Week Against Cancer, taking place from 25 – 31 May 2022. The findings demonstrate the need to further boost HPV awareness and knowledge, to lead to greater vaccine uptake and ultimately lower the prevalence of cancer-causing HPV.